We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.285 | -6.10% | 4.39 | 4.41 | 4.99 | 4.39 | 4.39 | 4.39 | 90,319 | 08:10:21 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.50 | 9.41M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 17/10/2020 15:05 | If you were a Corporate decision maker employed by Gilead and have just heard that the WHO have, essentially, confirmed that your product is ineffective against COVID 19 what would you do? - try and re-develop your ineffective product - start again - buy out the Company (Synairgen) that has developed the only 'game changing' COVID 19 product in the World CLUE: the last option will not only bring your Company massive returns but will also allow it to 'save face' from the rather embarrassing embarrassment. | irpy | |
| 17/10/2020 14:40 | "'On the brink of disaster': Europe's Covid fight takes a turn for the worse"Why hasn't 001 received EUA yet? | sloppyjoe2 | |
| 17/10/2020 12:44 | test - please ignore. | admak |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
